1. Home
  2. MDWD vs ISTR Comparison

MDWD vs ISTR Comparison

Compare MDWD & ISTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • ISTR
  • Stock Information
  • Founded
  • MDWD 2000
  • ISTR 2006
  • Country
  • MDWD Israel
  • ISTR United States
  • Employees
  • MDWD N/A
  • ISTR N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • ISTR Major Banks
  • Sector
  • MDWD Health Care
  • ISTR Finance
  • Exchange
  • MDWD Nasdaq
  • ISTR Nasdaq
  • Market Cap
  • MDWD 179.1M
  • ISTR 166.7M
  • IPO Year
  • MDWD 2014
  • ISTR 2014
  • Fundamental
  • Price
  • MDWD $16.80
  • ISTR $17.81
  • Analyst Decision
  • MDWD Strong Buy
  • ISTR Buy
  • Analyst Count
  • MDWD 1
  • ISTR 1
  • Target Price
  • MDWD $28.00
  • ISTR $13.50
  • AVG Volume (30 Days)
  • MDWD 64.7K
  • ISTR 45.4K
  • Earning Date
  • MDWD 08-14-2024
  • ISTR 10-17-2024
  • Dividend Yield
  • MDWD N/A
  • ISTR 2.26%
  • EPS Growth
  • MDWD N/A
  • ISTR N/A
  • EPS
  • MDWD N/A
  • ISTR 1.53
  • Revenue
  • MDWD $20,141,000.00
  • ISTR $80,646,000.00
  • Revenue This Year
  • MDWD $30.16
  • ISTR N/A
  • Revenue Next Year
  • MDWD $18.44
  • ISTR $13.81
  • P/E Ratio
  • MDWD N/A
  • ISTR $11.67
  • Revenue Growth
  • MDWD N/A
  • ISTR N/A
  • 52 Week Low
  • MDWD $7.26
  • ISTR $9.07
  • 52 Week High
  • MDWD $24.00
  • ISTR $18.99
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 41.82
  • ISTR 51.82
  • Support Level
  • MDWD $16.85
  • ISTR $18.37
  • Resistance Level
  • MDWD $17.48
  • ISTR $18.69
  • Average True Range (ATR)
  • MDWD 1.03
  • ISTR 0.40
  • MACD
  • MDWD -0.24
  • ISTR -0.04
  • Stochastic Oscillator
  • MDWD 12.79
  • ISTR 44.39

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About ISTR Investar Holding Corporation

Investar Holding Corp is a us-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

Share on Social Networks: